Skip to content
Wenlo
Sign in
← Markets

Bio-Techne Corp.

John L Higgins (Director) reports TECH insider transactions

4TECHFiled Sep 30, 2026, 12:13 PM ET· Period Sep 28, 2026

About this filing

Bio-Techne Corp. (TECH) filed Form 4 (insider transaction) with the SEC on Sep 30, 2026. Form 4 reports a company insider’s trades in the company’s shares.

Key facts

Insider
John L Higgins · Director
DateTransactionSharesPriceValueHeld afterOwnership
Sep 28, 2026M · exercise or conversion of a derivative+15,940$0.00$0.0082,816Direct
Sep 28, 2026F · tax withholding−5,562$72.51$403,300.6277,254Direct
Sep 28, 2026M · exercise or conversion of a derivativeStock Options (Right to Buy)−15,940$0.00$0.000Direct
Footnotes
  1. F1 The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

More TECH filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.